John B. Kaiser

Beluga Composites Corp. develops and manufactures immunodiagnostic testing systems and related therapeutic drug monitoring systems. The firm's products include single water tanks, double water tanks, container series tanks, compartment tanks and accessories. The company is headquartered in Montreal, Canada.

Crdentia Corp. provides healthcare staffing services, focusing on the areas of travel nursing, per diem staffing, contractual clinical services, and private duty home care. The company was founded in November 10, 2004 and is headquartered in Winter Park, FL.

Since 1995, Sensys Medical, Inc. (f.k.a. Instrumentation Metrics) has been diligently working on the development of a non-invasive blood glucose analyzer to assist those individuals with diabetes control their blood sugar levels. The Company intends to commercialize its Glucose Tracking System (GTSâ'¢), which will dramatically advance the practice of blood glucose monitoring and the science of diabetes disease management. Sensys Medical continues to advance the technologies necessary to successfully develop a device that is accurate, precise and simple to use in the hands of individuals. Sensys Medical scientists and engineers have furthered the understanding of non-invasive blood glucose measurement with advancements in the disciplines of tissue optics, multivariate statistics, optical engineering and analysis, detector materials, finite element analysis and applied computational fluid dynamics. These advances are continually tested in clinical trials and refined to ensure that individuals are capable of obtaining accurate non-invasive blood glucose measurements with minimal effort from the subject. As results from these trials become available, they will be shared through presentations and/or publications.

Aperon Biosystems Corp. manufactures and sells in-home device for daily measurement of exhaled nitric oxide (NO) for the management of asthma. The company was founded in 2001 and is headquartered in Menlo Park, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.